Back to an Aspirin a Day?
- 19 April 2002
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 296 (5567), 474-475
- https://doi.org/10.1126/science.1071702
Abstract
Nonsteroidal anti-inflammatory drugs such as aspirin have been used widely for decades but are associated with gastrointestinal side effects. The newer generation of anti-inflammatory drugs, the COX-2 selective inhibitors, do not have gastrointestinal side effects, but at least one of them is reported to lead to an increase in thrombotic events. In his Perspective, Vane discusses new findings ( Cheng et al .) that shed light on why inhibiting COX-2 rather than both COX isoforms may lead to dysregulation of cardiovascular homeostasis.Keywords
This publication has 9 references indexed in Scilit:
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone)The American Journal of Cardiology, 2002
- Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort studyThe Lancet, 2002
- The Coxibs, Selective Inhibitors of Cyclooxygenase-2New England Journal of Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- The Risk of Gastrointestinal Bleed, Myocardial Infarction, and Newly Diagnosed Hypertension in Users of Meloxicam, Diclofenac, Naproxen, and PiroxicamPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2Proceedings of the National Academy of Sciences, 1999
- Altered pain perception and inflammatory response in mice lacking prostacyclin receptorNature, 1997
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984